CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Medical Officer acquired 9,376 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,802 shares (option exercise)
- 4 Open-market buy Director bought 36,159 shares at $23.79 ($860,223)
- 4 Open-market buy Chief Clinical Dev. Officer bought 2,500 shares at $24.44 ($61,100)
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $19.95 ($49,875)
- 4 Open-market buy Director bought 100,000 shares at $20.69 ($2,069,000)
- 4 Shares withheld for taxes President and CEO gave up 54,720 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 24,569 shares (to pay taxes)
- 4 Exercise or conversion President and CEO acquired 49,460 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 4,024 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 4,670 shares (option exercise)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Shares withheld for taxes Director gave up 1,746 shares (to pay taxes)
- 4 Exercise or conversion President and CEO acquired 2,801 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President and CEO gave up 53,965 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 7,472 shares (option exercise)
Page 5 of 30 · 591 filings